Literature DB >> 15461630

Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation.

D Wynne Jones1, Geoffrey Russell, Sarah L Allford, Kathryn Burdon, Gregory A Hawkins, Donald W Bowden, Sophie Minaee, Andrew D Mumford.   

Abstract

An elderly patient with no abnormal bleeding presented with prolongation of the activated partial thromboplastin time (aPTT). Preincubation of plasma with aPTT reagent caused shortening of the abnormal clotting time. Plasma prekallikrein (PK) activity and antigen were <5 u/dL. Molecular analysis showed a homozygous Arg94Stop substitution in the PK gene, predicted to prevent expression of the mutant allele. The five heterozygous offspring of the proband each showed a normal aPTT but reduced PK activity and antigen. This is the first description of a kindred in which absence of expression of one or both PK alleles has been confirmed by genotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461630     DOI: 10.1111/j.1365-2141.2004.05180.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.

Authors:  K-A Steen Burrell; J Layzer; B A Sullenger
Journal:  J Thromb Haemost       Date:  2017-08-02       Impact factor: 5.824

2.  A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.

Authors:  Ivy Riano; Klaorat Prasongdee
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec

3.  Novel insights into the molecular pathogenesis of CYP4V2-associated Bietti's retinal dystrophy.

Authors:  Galuh D N Astuti; Vincent Sun; Miriam Bauwens; Ditta Zobor; Bart P Leroy; Amer Omar; Bernhard Jurklies; Irma Lopez; Huanan Ren; Volkan Yazar; Christian Hamel; Ulrich Kellner; Bernd Wissinger; Susanne Kohl; Elfride De Baere; Rob W J Collin; Robert K Koenekoop
Journal:  Mol Genet Genomic Med       Date:  2014-09-15       Impact factor: 2.183

Review 4.  The Effects of the Contact Activation System on Hemorrhage.

Authors:  Fabrício Simão; Edward P Feener
Journal:  Front Med (Lausanne)       Date:  2017-07-31

Review 5.  Genetics of equine bleeding disorders.

Authors:  Anna R Dahlgren; Fern Tablin; Carrie J Finno
Journal:  Equine Vet J       Date:  2020-06-23       Impact factor: 2.888

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.